Dementia study: Bilateral DLPFC
Official title Investigating Different Frequencies of Transcranial Electrical Stimulations in Dementia Population
ClinicalTrials.gov ID: NCT06547021
What this study is testing
- What it's testing
- The study wants to find which type of transcranial electrical stimulation (tES) best improves thinking and memory when paired with cognitive training. It also looks at brain and balance changes using several monitoring tools.
- Who it's for
- Older adults who have dementia and can attend study visits.
- What's involved
- Participants will receive either real or placebo tES while doing cognitive exercises. They will also have brain activity (EEG), blood flow (fNIRS), vestibular function (EVestG), and balance (accelerometers) measured during the study.
- Time commitment
- The study lasts several weeks, with multiple visits for stimulation, training, and testing sessions. Participants will need to attend all scheduled appointments to complete the protocol.
You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 95
You may be able to join if
- MoCA score between 5 and 24
- Between the age of 50 and 95 years old
You likely can't join if
- Being diagnosed with Parkinson's, Parkinsonian dementia, Huntington disease, speech significant aphasia and intellectual disability, major...
- Having a History of epileptic seizures or epilepsy
- Inability to adequately communicate in English
- Impaired vision or hearing severe enough to impair performance in cognitive tests
- Current substance abuse disorder
- Currently participating in another therapeutic study for dementia
See the full eligibility criteria
- MoCA score between 5 and 24
- Between the age of 50 and 95 years old
- Being diagnosed with Parkinson's, Parkinsonian dementia, Huntington disease, speech significant aphasia and intellectual disability, major depression/anxiety, bipolar disorder, schizophrenia or any other major mood...
- Having a History of epileptic seizures or epilepsy
- Inability to adequately communicate in English
- Impaired vision or hearing severe enough to impair performance in cognitive tests
- Current substance abuse disorder
- Currently participating in another therapeutic study for dementia
- Change to medication for Alzheimer's disease, dementia, or depression
The study team makes the final eligibility decision.
Where it is enrolling
- Winnipeg, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 95 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Winnipeg, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.